Implementation deadlines

IMPLEMENTATION SCHEDULE

 

 

  • June 2016 : For new marketing authorization

​​​

 

  • December 2017 : For products already marketed

 

 

 

CURRENT REGULATION

The ICH Q3D guideline comes into effect in the three pharmacopeias (Europe, US and Japan).                                                                                                                                                                                                             

USP -232- ELEMENTAL IMPURITIES LIMITS 
USP -233- ELEMENTAL IMPURITIES PROCEDURES

JP 1.07 "HEAVY METALS LIMIT TEST"
PH. EUR: 5.20, 2.4.20, 2.4.8

 

 

 

To fullfill ICH Q3D requirements before this deadlines expired, we develop Elemental Impurities Implementation of Risk Assessment Reports, for both API manufacturers and drug product manufacturers. You can contact us regarding a QUOTATION REQUEST for an ICH Q3D report development.

Latest news

CPhI 2017

Socosur Chem is exhibiting again on Indis Associates (of which Exim Corp.) botth 80F02. An...(...)

AZIERTA exclusive agency for INDIA

The Azierta Socosur agreement on PDE, OEL, ICHQ and other toxicology services have been extended to...(...)

New Service - ICH Q3D

New competitive service as part of Azierta cooperation: ICH Q3D – Elemental i...(...)

Exclusive agency for Azierta PDE monographs

Azierta and Socosur just entered an exclusive agency agreement for PDE monographs elaborated by...(...)

Stay in touch